Table 1 Patient characteristics
From: Role of breath-hold lung PET in stage IA pulmonary adenocarcinoma
Parameter | Data |
|---|---|
Sex* | |
M | 25 (53.19) |
F | 22 (46.81) |
Age (years) | 62.64 ± 12.66 (36–84) |
Weight (kg) | 65.06 ± 11.51 (43.0–91.0) |
Height (cm) | 167.66 ± 7.67 (144–184) |
Body mass index (BMI, kg/m2) | 23.09 ± 3.47 (15.21–29.00) |
Blood glucose level (mg/dL) | 107.95 ± 19.44 (82.80–144) |
Injection dose (MBq) | 185.30 ± 35.55 (120.25–291.93) |
Injection dose per weight (MBq/kg) | 2.85 ± 0.19 (2.34–3.21) |
Waiting time (min) | 67.94 ± 6.85 (55–79) |
Lesion size (mm) | 17.79 ± 5.81 (6.32–26.64) |
Lesion volume (mm3) | 2101.73 ± 1531.36 |
Lesion location* | |
Left lung | 28 (59.57) |
Right lung | 19 (40.43) |
Upper lobes | 29 (61.70) |
Middle and lower lobes | 18 (38.30) |